Skip to main content
Also available in 1 other language

Русский

Beginner 5 min read

Risk-Reducing Surgery for Inherited Cancer Variants

Risk-reducing mastectomy and salpingo-oophorectomy: how much risk they remove, what they cost you, and the alternatives worth weighing first.

NCI source:National Cancer Institute

Review status: AI-assisted, source checked. Not reviewed by a clinician. How we check pages

The short answer

Risk-reducing surgery removes healthy tissue before cancer starts. It works — bilateral mastectomy cuts breast cancer risk by at least 95% in BRCA carriers — but it is irreversible and carries real costs. Surveillance and medication are recognized alternatives, and declining surgery is a legitimate choice.

  • Bilateral risk-reducing mastectomy lowers breast cancer risk by at least 95% in people with a harmful BRCA1 or BRCA2 variant, and by up to 90% in those with a strong family history.

  • Removing the ovaries and fallopian tubes substantially reduces ovarian cancer risk; evidence on whether it also lowers breast cancer risk has been inconsistent.

  • Ovarian surgery is discussed more firmly than breast surgery because no screening test reliably finds ovarian cancer early.

  • Removing the ovaries before natural menopause causes immediate surgical menopause, with effects on sleep, mood, sexual function, bone, and heart health.

Choose how you want to read this

The whole article, with every detail and caution.

If a genetic test showed you carry an inherited variant that raises cancer risk, you may hear about surgery to prevent cancer. This overview compares the main operations, their costs, and the other paths open to you.

What these operations are

Risk-reducing surgery takes out healthy tissue before cancer starts. It is offered to people whose inherited risk of that cancer is high. It is one option among several. It is not an automatic next step after a positive genetic test.

The two discussed most often are:

  • Bilateral risk-reducing mastectomy — removal of both breasts. In people with a harmful BRCA1 or BRCA2 variant, this cuts breast cancer risk by at least 95%. With a strong family history, it cuts risk by up to 90%. It cannot bring risk to zero. Some breast tissue always remains.
  • Risk-reducing salpingo-oophorectomy — removal of both ovaries and fallopian tubes. This sharply lowers the risk of ovarian, fallopian tube and peritoneal cancer. Whether it also lowers breast cancer risk is less clear. Studies have not agreed.

For Lynch syndrome, your team may raise a third option. It is hysterectomy along with removal of the ovaries and tubes. That lowers uterine and ovarian cancer risk. It usually comes up once childbearing is complete.

Why ovarian surgery is discussed differently

No screening test finds ovarian cancer early in a reliable way. CA-125 blood testing has not been shown to cut deaths from it. Nor has transvaginal ultrasound.

That gap is why surgery is raised more firmly for ovarian risk. Breast cancer is different. It has good surveillance: yearly mammography and breast MRI, often spaced six months apart. Close screening is a real alternative there, and it does find cancers early. For ovarian cancer, there is no such option.

The costs, stated plainly

Removing the ovaries before natural menopause brings on surgical menopause at once. Hot flashes, broken sleep and vaginal dryness can start within days rather than over years. So can changes in libido, anxiety and low mood. There are longer-term questions about bone and heart health too. Hormone therapy is often suitable for people who have not had breast cancer. Raise it before surgery, not after.

Mastectomy carries the usual surgical risks of bleeding and infection. It also changes sensation for good. Nipple sensation is lost, which affects sexual response for many people. Worries about body image are common, and so are grief and anxiety. They are not a sign the decision was wrong. Reconstruction is a separate set of choices, with its own timeline and revision rates. Nipple-sparing methods look more natural. They also leave slightly more tissue behind.

Both operations are permanent.

The alternatives

Surgery is not the only path.

  • Enhanced surveillance — for breast risk, yearly mammography plus MRI with a clinical exam. It usually starts earlier than routine screening.
  • Risk-reducing medication — tamoxifen or raloxifene lower breast cancer risk in eligible people. Their effect in BRCA carriers is less clear.
  • Oral contraceptives — linked to roughly 30% to 50% lower ovarian cancer risk, including in BRCA carriers.

Timing is a choice too. Many people have salpingo-oophorectomy within an age window set by their gene and their family's pattern. They then put off mastectomy, or turn it down for good.

How the decision usually gets made

There is no single right answer. The right answer for you shifts with your age. It shifts with whether you want children, what your family has been through, and how you handle uncertainty.

What helps is getting the right people around you first. Start with a genetic counselor, who can confirm what your variant means. Add a breast or gynecologic surgeon. Add a reconstructive surgeon if that applies, and a menopause specialist. Then get a second opinion. Many centers will arrange all of it with no expectation that you go ahead.

Choosing surveillance now and revisiting surgery in five years is entirely reasonable. So is deciding quickly. Turning down risk-reducing surgery does not mean you are taking your risk lightly. It is one of the recognized options, and the guidelines treat it that way.

Sources

A doctor in a white coat with a stethoscope shows a woman a surgery information sheet during a consultation

Common questions

Does risk-reducing mastectomy remove all my risk?

No. It reduces breast cancer risk by at least 95% in BRCA carriers, but some breast tissue always remains, so risk cannot reach zero. Nipple-sparing techniques look more natural after reconstruction and leave slightly more tissue behind than total mastectomy.

Why does my team push harder on removing my ovaries than my breasts?

Because the alternatives differ. For breast cancer, annual mammography plus MRI is effective surveillance that finds cancers early. For ovarian cancer there is no screening test shown to reduce deaths, so surgery is the main way to lower that specific risk.

Can I take hormone therapy after my ovaries are removed?

It is often appropriate for people who have not had breast cancer, and it can make surgical menopause considerably more manageable. This is a question to settle before surgery rather than after, ideally with a clinician who specializes in menopause.

Is it wrong to decline surgery?

No. Enhanced surveillance, risk-reducing medication, and oral contraceptives are all recognized options, and guidelines treat declining surgery as a legitimate path rather than a failure. Many people choose surveillance and revisit the decision years later.

How long do I have to decide?

For most inherited variants there is no emergency. Risk accumulates over years, not weeks. That leaves room to see a genetic counselor, a surgeon, a reconstructive surgeon, and get a second opinion before committing to anything irreversible.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Talk to a person

Talk with a trained specialist or navigator

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Prepared by Cancer Explained's AI-assisted editorial system

Written from National Cancer Institute material and compared with the source cited below.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Written by: Cancer ExplainedSources last checked: 2026-08-13 what this meansLast updated: 2026-08-18Next planned review: 2027-07-30

Review details and limits

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Source checked. This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

More on this topic

Words to know

Tap any term to see what it means.

Browse the full glossary →

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Source checked — This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.